You are on page 1of 2

GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS TO REACH $175.6 BILLION IN 2016 Wellesley, Mass.

In a recent release, ADVANCED DRUG DELIVERY SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS (PHM006H) from BCC Research (www.bccresearch.com), the global market for advanced drug delivery systems is estimated to reach nearly $137.9 billion in 2011 and $175.6 billion by 2016 at a compound annual growth rate (CAGR) of 5%. The global market for advanced drug delivery systems can be broken down into three regions the U.S., Europe, and the rest of the world. The U.S. region accounted for $81.6 billion in 2011 and in 2016 should be worth $102.6 billion, a CAGR of 4.7%. The European region, worth nearly $37.5 billion in 2011, should be worth $49.1 billion in 2016, a CAGR of 5.6%. The rest of the world accounted for nearly $18.8 billion in 2011 and in 2016 should be worth nearly $23.8 billion, a CAGR of 4.8%. Healthcare costs are causing a need for alternative drug delivery technologies. The drug delivery industry has emerged from the shadow of the pharmaceutical industry and has become an influential factor for pharmaceutical market growth. Drug delivery technologies are considered significant drivers of the global pharmaceutical and biopharmaceutical industry. Because pharmaceutical and biopharmaceutical companies have recognized the strategic advantage of drug delivery technologies, they are applying these advantages to their existing products to protect them from market erosion by generic versions. The drug delivery market is a well-established and important sector of the pharmaceutical industry. The market is evolving at a rapid rate with continuous research efforts in which numerous drug delivery systems are being developed to improve many of the pharmacological properties of existing conventional drugs. This study contributes to the areas of market growth in drug delivery systems from the point of view of manufacturers and the users, and, as such, this report will be of interest largely to the pharmaceutical and biopharmaceutical industries, as well as clinics, hospitals, and research institutes.

SUMMARY FIGURE GLOBAL REVENUE OF ADVANCED DRUG DELIVERY SYSTEMS BY REGION, 2009-2016 ($ MILLIONS)

Source: BCC Research Advanced Drug Delivery Systems: Technologies and Global Markets (PHM006H) Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: editor@bccresearch.com as the source and publisher, along with report number, which can be found in the first paragraph of this release.

You might also like